Inhibition of CTH in mouse GBM cells with a brain-permeable pharmacological inhibitor (PAG) or knockdown with siRNA (siCTH) results in lower GBM cell proliferation and migration by an H2S-dependent mechanism, since the effects of CTH inhibition are attenuated by the H2S donor, NaSH. The gene discussed is CTH; the disease is glioblastoma.